Latest Competition News

Moho Resources has identified a significant 4 km by 1 km gold soil anomaly at its Silver Swan North Project in Western Australia’s Eastern Goldfields, marking a promising new chapter in the company’s exploration efforts.

Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.

HITIQ Limited has announced a non-renounceable entitlement offer to raise up to $2.92 million, supported by partial underwriting from GBA Capital and accompanied by new options issuance. The capital raise aims to fund expansion, product development, and operational growth.

Chimeric Therapeutics reports encouraging interim results from its ADVENT-AML Phase 1B trial, with two of three newly diagnosed AML patients achieving remission using their novel CORE-NK cell therapy combined with standard treatment.

Aspen Group announces a $74 million equity raise alongside robust earnings growth and unchanged FY25 guidance, positioning itself for expansion in Australia’s tight housing market.

Mesoblast has been granted a seven-year orphan-drug exclusivity by the FDA for its cell therapy Ryoncil, reinforcing its market position in treating steroid-refractory acute graft versus host disease in children.

Peak Rare Earths is poised for acquisition by Shenghe Resources in a deal valuing the company at A$150.5 million, supported by a A$7.5 million entitlement offer to fund ongoing development and transaction costs.

Peak Rare Earths Limited has agreed to be acquired by Ganzhou Chenguang Rare Earths New Material Co., Ltd., a subsidiary of Shenghe Resources, in a deal valuing Peak at A$150.5 million plus proceeds from a proposed entitlement offer. The transaction offers Peak shareholders a significant premium and aims to accelerate development of the Ngualla Rare Earth Project.

Genetic Technologies Limited has announced significant leadership changes, appointing Michael Walker as Executive Chairman and Managing Director, alongside new executive and board members.

Cleanaway Waste Management has received regulatory clearance from the ACCC to acquire Citywide, marking a significant step in its expansion strategy with completion expected by fiscal year-end 2025.

The Australian Competition and Consumer Commission (ACCC) has decided not to oppose Cleanaway Waste Management’s proposed acquisition of Citywide Waste, finding the deal unlikely to reduce competition in Melbourne’s putrescible waste services market.

Trinex Minerals announces a A$1 million two-tranche capital raising, including director participation and plans for a potential share consolidation.